Edinburgh, United Kingdom

Gordon Kennovin

USPTO Granted Patents = 8 


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Edinburgh, GB (2018 - 2023)
  • Central Scotland, GB (2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gordon Kennovin

Introduction

Gordon Kennovin is a prominent inventor based in Edinburgh, GB, known for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, he has focused on developing innovative formulations and synthesis processes that have the potential to revolutionize cancer treatment.

Latest Patents

Among his latest patents, Kennovin has developed formulations of phosphoramidate derivatives of nucleoside drugs. This invention relates to pharmaceutical formulations and formulation strategies of protides, particularly those useful in the treatment of cancer, such as NUC-3373 and NUC-7738. These formulations comprise a polar aprotic solvent, for example, dimethyl acetamide (DMA). Additionally, he has patented a process for the preparation of certain 5'-phosphoramidate nucleotide diastereoisomers, which include phosphoramidates beneficial for cancer treatment.

Career Highlights

Gordon Kennovin is currently associated with Nucana Plc, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in advancing the understanding and application of nucleoside derivatives in medical treatments.

Collaborations

Throughout his career, Kennovin has collaborated with notable professionals in the field, including Hugh Griffith and Venkata Lakshmi Narasimha Rao Dammalapati. These collaborations have further enhanced the impact of his inventions and research.

Conclusion

Gordon Kennovin's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a leading inventor in the industry. His patents reflect a commitment to improving therapeutic options for patients, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…